Cases and evidence
Current product policyLast updated September 30, 2026
Choose a topic, then explore how a case reaches a judgment.
Prioritize a scoped, reversible risk-tiered governance pilot: given the lack of evidence on current coverage and control costs, focusing first on validation practices for potentially higher-impact models is more controllable and reversible than a simultaneous full rollout
Read the full case →Start by defining a small set of shared data responsibilities and principles, while preserving reversible autonomy boundaries: evidence shows the root causes of conflict have not been disaggregated (F6), the necessity of differences has not been proven (F4), and studios have raised disruption-risk concerns (F3). Under this uncertainty, a reversible, small-scope starting point is preferable to irreversible full centralization.
Read the full case →Prioritize a time-bound, stoppable triage of asset use, obligations, and operational dependencies as the first batch of actions; since cash runway, termination costs, legal conditions, and critical service dependencies have not been verified, the irreversible risk of full-scale disposal is too high at this scale (1,700 locations / 46,000 employees)
Read the full case →First establish a very short, stoppable gate covering task necessity, staff safety, and accountability, confirming protections and voluntariness before deciding on on-site or remote support; this path preserves reversibility and avoids irreversible staff exposure risk while protections remain unclear.
Read the full case →Recommend first launching a time-bound, auditable assessment gate, while applying immediate, reversible risk controls at known drought- and water-stressed sites, and deciding on full-scale investment expansion once a comparative baseline is established.
Read the full case →Prioritize a triage-and-validate path: with data feasibility, trend authenticity, and model downside risk all unknown, first gather evidence through a limited, reversible pilot before deciding whether to scale into a full-scale overhaul.
Read the full case →Adopt a time-boxed representative pilot, first validating data definitions, control consistency, and decision speed using high-risk accounts and representative business lines, before deciding whether to consolidate, since the proportional risk from fragmentation and data quality lack shared evidence
Read the full case →Adopt time-boxed mapping of critical products while concurrently protecting known single points, as this balances speed with an evidence base under hard stops on quality and patient supply, and actions can be adjusted based on mapping results
Read the full case →First launch a time-bound pilot covering representative functions and cross-functional dependencies, while simultaneously setting compliance escalation and stop thresholds; decide on full rollout scope only after validating granularity and participation load
Read the full case →Adopt a phased verification approach: first lock down critical access, segregation of duties, and the deliverable scope for regulatory deadlines, then progressively expand integration and cloud migration—because gaps and rollback capability remain unverified, and full replication would carry existing exposure unchanged into two new environments
Read the full case →Recommendation: retain the candidate slate and converge gradually through strategy, readiness, and governance gates, as this preserves adjustability over the five-year uncertain horizon while balancing fairness and retention (F1, F2, F3, F6)
Read the full case →Recommendation: prioritize a time-boxed pilot. Given three key uncertainties—root cause, accessibility, and capacity—the pilot generates decision-grade evidence within controlled risk while preserving the option for network-wide rollout
Read the full case →Run a clinically supervised pilot first, limited to a defined set of chief complaints and patient populations, preserving full record access and human judgment. Consider expansion only after recall, misleading-association, bias, and workflow validation pass.
Read the full case →Independent teaching simulation. The named consulting firm supplied the public source only; it did not use, review, endorse, sponsor, certify or commission Minerva Advisor. This evidence does not claim customer results, ROI or a permanent service-level guarantee.
All cases and validation →MINERVA DECISION READINESS REVIEW
Minerva separates evidence, inference and unknowns, then shows options, the strongest objection and what would reverse the recommendation.
Start a Minerva Decision Readiness ReviewBring a real, de-identified decision. Google sign-in and product access are required; your plan and Decision Credits apply. You remain the decision-maker, and no email or external action is sent automatically.